Abstract
The purpose of the present study was to study the impacts of eplerenone (EPL), an antagonist of mineralocorticoid receptors (MR), on atrial fibrosis in a mouse model with selective fibrosis in the atrium, and to explore the possible mechanisms. Using mutant TGF-β1 transgenic (Tx) mice, we first demonstrated that EPL inhibited atrial fibrosis specifically and decreased macrophage accumulation in the atria of these mice. Results from immunohistochemistry and western blotting showed that EPL attenuated protein expression of fibrosis-related molecules such as connective tissue growth factor (CTGF) and fibronectin in the atria of Tx mice. In culture, EPL inhibited gene expression of fibrosis-related molecules such as fibronectin, α-SMA, and CTGF in TGF-β1-stimulated atrial fibroblasts. Finally, using a co-culture system, we showed that TGF-β1-stimulated atrial fibroblasts induced migration of macrophages and this was blocked by EPL. EPL also blocked TGF-β1-induced gene expression of intedeukin-6 (IL-6) in atrial fibroblasts. Therefore, we conclude that EPL attenuated atrial fibrosis and macrophage infiltration in Tx mice. TGF-β1 and IL-6 were involved in the impacts of EPL on activation of atrial fibroblasts and interactions between fibroblasts and macrophages.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aulin, J., Siegbahn, A., Hijazi, Z., Ezekowitz, M.D., Andersson, U., Connolly, S.J., Huber, K., Reilly, P.A., Wallentin, L., and Oldgren, J. (2015). Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J 6, 1151–1160.
Burstein, B., and Nattel, S. (2008). Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 8, 802–809.
Chen, X., Liu, X., Wang, Q., Zhang, M., Guo, M., Liu, F., Jiang, W., and Zhou, L. (2015a). Pioglitazone inhibits angiotensin II-induced atrial fibroblasts proliferation via NF-kappaB/TGF-beta1/TRIF/TRAF6 pathway. Exp Cell Res 1, 43–55.
Chen, X., Zhang, D., Zhang, M., Guo, M., Zhan, Y., Liu, F., Jiang, W., Zhou, L., Zhao, L., Wang, Q., and Liu, X. (2015b). TRIF promotes angiotensin II-induced cross-talk between fibroblasts and macrophages in atrial fibrosis. Biochem Biophys Res Commun 1, 100–105.
Dabrowski, R., Borowiec, A., Smolis-Bak, E., Kowalik, I., Sosnowski, C., Kraska, A., Kazimierska, B., Wozniak, J., Zareba, W., and Szwed, H. (2010). Effect of combined spironolactone-beta-blocker +/- enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). Am J Cardiol 11, 1609–1614.
Duan, S. (2014). Mineralocorticoid receptor: a critical player in vascular remodeling. Sci China Life Sci 57, 809–817.
Ehrlich, J.R., Hohnloser, S.H., and Nattel, S. (2006). Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 5, 512–518.
Nakajima, H., Nakajima, H.O., Salcher, O., Dittiè, A.S., Dembowsky, K., Jing, S., and Field, L.J. (2000). Atrial but notventricular fibrosis in mice expressing a mutant transforming growthfactor-beta(1) transgene in the heart. Circ Res 86, 571–579.
Zhao, J., Li, J., Li, W., Li, Y., Shan, H., Gong, Y., and Yang, B. (2010). Effects of spironolactone on atrial structuralremodelling in a canine model of atrial fibrillation produced byprolonged atrial pacing. Br J Pharmacol 159, 1584–1594.
Jia, G., Habibi, J., DeMarco, V.G., Martinez-Lemus, L.A., Ma, L., Whaley-Connell, A.T., Aroor, A.R., Domeier, T.L., Zhu, Y., Meininger, G.A., Barrett Mueller, K., Jaffe, I.Z., and Sowers, J.R. (2015). Endothelial mineralocorticoid receptor deletion prevents diet-Induced cardiac diastolic dysfunction in females. Hypertension 6, 1159–1167.
Kothari, P., Pestana, R., Mesraoua, R., Elchaki, R., Khan, K.M., Dannenberg, A.J., and Falcone, D.J. (2014). IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages. J Immunol 1, 349–357.
Lavall, D., Selzer, C., Schuster, P., Lenski, M., Adam, O., Schafers, H.J., Bohm, M., and Laufs, U. (2014). The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation. J Biological Chem 10, 6656–6668.
Ma, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., and Du, J. (2012). Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One 5, e35144.
Allessie, M., Ausma, J., and Schotten, U. (2002). Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 54, 230–246.
Mayyas, F., Alzoubi, K.H., and Van Wagoner, D.R. (2013). Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. Int J Cardiol 6, 5135–5142.
Nattel, S. (2002). New ideas about atrial fibrillation 50 years on. Nature, 219–226.
Milliez, P., Deangelis, N., Rucker-Martin, C., Leenhardt, A., Vicaut, E., Robidel, E., Beaufils, P., Delcayre, C., and Hatem, S.N. (2005). Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J, 2193–2199.
Roldan, V., Marin, F., Diaz, J., Gallego, P., Jover, E., Romera, M., Manzano-Fernandez, S., Casas, T., Valdes, M., Vicente, V., and Lip, G.Y. (2012). High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation. J Thromb Haemost 8, 1500–1507.
Struthers, A.D. (2004). The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail 5, 539–545.
Swedberg, K., Zannad, F., McMurray, J.J., Krum, H., van Veldhuisen, D.J., Shi, H., Vincent, J., Pitt, B., and EMPHASIS-HF Study Investigators. (2012). Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. J Am Coll Cardiol 18, 1598–1603.
Usher, M.G., Duan, S.Z., Ivaschenko, C.Y., Frieler, R.A., Berger, S., Schutz, G., Lumeng, C.N., and Mortensen, R.M. (2010). Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 9, 3350–3364.
van Amerongen, M.J., Harmsen, M.C., van Rooijen, N., Petersen, A.H., and van Luyn, M.J. (2007). Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am J Pathol 3, 818–829.
Wynn, T.A. (2007). Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 3, 524–529.
Zhang, W., Zheng, X., Du, L., Sun, J., Shen, Z., Shi, C., Sun, S., Zhang, Z., Chen, X., Qin, M., Liu, X., Tao, J., Jia, L., Fan, H., Zhou, B., Yu, Y., Ying, H., Hui, L., Liu, X., Yi, X., Liu, X., Zhang, L., and Duan, S. (2015a). High salt primes a specific activation state of macrophages, M(Na). Cell Res 8, 893–910.
Zhang, Y., Wang, J., Li, H., Yuan, L., Wang, L., Wu, B., and Ge, J. (2015b). Hydrogen sulfide suppresses transforming growth factor-β1-induced differentiation of human cardiac fibroblasts into myofibroblasts. Sci China Life Sci 58, 1126–1134.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Contributed equally to this work
This article is published with open access at link.springer.com
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Chen, X., Zhang, W., Wang, Q. et al. Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mice. Sci. China Life Sci. 59, 1042–1047 (2016). https://doi.org/10.1007/s11427-016-0037-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-0037-y